Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up.

Standard

Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up. / Grosse, A; Schreer, I; Frischbier, H J; Maass, H; Löning, Thomas; Bahnsen, J.

In: INT J RADIAT ONCOL, Vol. 38, No. 4, 4, 1997, p. 761-767.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Grosse, A, Schreer, I, Frischbier, HJ, Maass, H, Löning, T & Bahnsen, J 1997, 'Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up.', INT J RADIAT ONCOL, vol. 38, no. 4, 4, pp. 761-767. <http://www.ncbi.nlm.nih.gov/pubmed/9240644?dopt=Citation>

APA

Vancouver

Grosse A, Schreer I, Frischbier HJ, Maass H, Löning T, Bahnsen J. Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up. INT J RADIAT ONCOL. 1997;38(4):761-767. 4.

Bibtex

@article{a3f3e6483a054b3e987c963a21b07011,
title = "Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up.",
abstract = "PURPOSE: The following article is a review of 23 years of breast-conserving therapy in our hospital. This study was performed to assess and improve the follow-up care of women with early breast cancer and to evaluate whether or not biannual mammogram is useful. METHODS AND MATERIALS: Between 1972 and December 1995, 3072 women with pathological size pT1 and pT2 breast cancer were treated with conservative surgery and radiation therapy. Eighty-five patients developed a recurrence in the treated breast as the first site of failure, 12 of which had positive axillary nodes. In the following patient study, those with an noninvasive recurrence were excluded. A retrospective assessment of the entire mammographic course was made, starting with the mammogram at the time of original diagnosis to the mammogram of the recurrence. RESULTS: In our study group the probability for local failure ranged from 1 to 2% per year. At 5 and 10 years the actuarial rates were 5 and 10%. The median time to recurrence was 41 months (range 8-161). Twenty-six (31%) recurrences were detected by mammography alone, 10 (12%) by clinical examination only, and 35 (41%) by both methods. For the patients with an ipsilateral recurrence, the overall actuarial 5- and 10-year survival after treatment was 87 and 70%, respectively. The 5-year actuarial rate of survival from salvage mastectomy was 61%. CONCLUSION: Considering the high percentage of recurrences detectable by mammography and the possibility of detection within a short-term interval, we think biannual mammographic follow-up is appropriate for the first years following breast-conserving therapy.",
author = "A Grosse and I Schreer and Frischbier, {H J} and H Maass and Thomas L{\"o}ning and J Bahnsen",
year = "1997",
language = "Deutsch",
volume = "38",
pages = "761--767",
journal = "INT J RADIAT ONCOL",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up.

AU - Grosse, A

AU - Schreer, I

AU - Frischbier, H J

AU - Maass, H

AU - Löning, Thomas

AU - Bahnsen, J

PY - 1997

Y1 - 1997

N2 - PURPOSE: The following article is a review of 23 years of breast-conserving therapy in our hospital. This study was performed to assess and improve the follow-up care of women with early breast cancer and to evaluate whether or not biannual mammogram is useful. METHODS AND MATERIALS: Between 1972 and December 1995, 3072 women with pathological size pT1 and pT2 breast cancer were treated with conservative surgery and radiation therapy. Eighty-five patients developed a recurrence in the treated breast as the first site of failure, 12 of which had positive axillary nodes. In the following patient study, those with an noninvasive recurrence were excluded. A retrospective assessment of the entire mammographic course was made, starting with the mammogram at the time of original diagnosis to the mammogram of the recurrence. RESULTS: In our study group the probability for local failure ranged from 1 to 2% per year. At 5 and 10 years the actuarial rates were 5 and 10%. The median time to recurrence was 41 months (range 8-161). Twenty-six (31%) recurrences were detected by mammography alone, 10 (12%) by clinical examination only, and 35 (41%) by both methods. For the patients with an ipsilateral recurrence, the overall actuarial 5- and 10-year survival after treatment was 87 and 70%, respectively. The 5-year actuarial rate of survival from salvage mastectomy was 61%. CONCLUSION: Considering the high percentage of recurrences detectable by mammography and the possibility of detection within a short-term interval, we think biannual mammographic follow-up is appropriate for the first years following breast-conserving therapy.

AB - PURPOSE: The following article is a review of 23 years of breast-conserving therapy in our hospital. This study was performed to assess and improve the follow-up care of women with early breast cancer and to evaluate whether or not biannual mammogram is useful. METHODS AND MATERIALS: Between 1972 and December 1995, 3072 women with pathological size pT1 and pT2 breast cancer were treated with conservative surgery and radiation therapy. Eighty-five patients developed a recurrence in the treated breast as the first site of failure, 12 of which had positive axillary nodes. In the following patient study, those with an noninvasive recurrence were excluded. A retrospective assessment of the entire mammographic course was made, starting with the mammogram at the time of original diagnosis to the mammogram of the recurrence. RESULTS: In our study group the probability for local failure ranged from 1 to 2% per year. At 5 and 10 years the actuarial rates were 5 and 10%. The median time to recurrence was 41 months (range 8-161). Twenty-six (31%) recurrences were detected by mammography alone, 10 (12%) by clinical examination only, and 35 (41%) by both methods. For the patients with an ipsilateral recurrence, the overall actuarial 5- and 10-year survival after treatment was 87 and 70%, respectively. The 5-year actuarial rate of survival from salvage mastectomy was 61%. CONCLUSION: Considering the high percentage of recurrences detectable by mammography and the possibility of detection within a short-term interval, we think biannual mammographic follow-up is appropriate for the first years following breast-conserving therapy.

M3 - SCORING: Zeitschriftenaufsatz

VL - 38

SP - 761

EP - 767

JO - INT J RADIAT ONCOL

JF - INT J RADIAT ONCOL

SN - 0360-3016

IS - 4

M1 - 4

ER -